about
Emerging concepts in pancreatic cancer medicine: targeting the tumor stromaMolecular targets for the treatment of pancreatic cancer: Clinical and experimental studiesDiet and Pancreatic Cancer PreventionPulsed High-Intensity Focused Ultrasound Enhances Delivery of Doxorubicin in a Preclinical Model of Pancreatic Cancer.Epidemiology of pancreatic cancerSelected cytokines in patients with pancreatic cancer: a preliminary report.Pancreatic biomarkers: could they be the answer?Current Status and Future Directions for Screening Patients at High Risk for Pancreatic Cancer.The complex landscape of pancreatic cancer metabolismPancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluationNovel strategies for managing pancreatic cancer.Stromal microRNA-21 levels predict response to 5-fluorouracil in patients with pancreatic cancerNanomedicine strategies to overcome the pathophysiological barriers of pancreatic cancer.Hippo pathway mediates resistance to cytotoxic drugs.Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells.Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancerUse of a novel herbal medicine in a 75-year-old woman with multi-metastatic pancreatic cancer: A case report and review of the literature.A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.Apigenin: Selective CK2 inhibitor increases Ikaros expression and improves T cell homeostasis and function in murine pancreatic cancer.Multivalent Small-Molecule Pan-RAS Inhibitors.Mesothelin's minimal MUC16 binding moiety converts TR3 into a potent cancer therapeutic via hierarchical binding events at the plasma membranePharmacodynamic Modeling of Cell Cycle Effects for Gemcitabine and Trabectedin Combinations in Pancreatic Cancer CellsIdentification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axisMolecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer.Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.Pancreaticoduodenectomy with vascular resection for pancreatic head adenocarcinoma.Efficacy of extracorporeal ultrasound-guided high intensity focused ultrasound: An evaluation based on controlled trials in China.Numb/Notch signaling pathway modulation enhances human pancreatic cancer cell radiosensitivity.Safety of palliative chemotherapy in advanced pancreatic cancer.Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer.Escin Chemosensitizes Human Pancreatic Cancer Cells and Inhibits the Nuclear Factor-kappaB Signaling Pathway.FAM83A is amplified and promotes cancer stem cell-like traits and chemoresistance in pancreatic cancerAcquired resistance of pancreatic cancer cells to cisplatin is multifactorial with cell context-dependent involvement of resistance genes.The TGFβ-SMAD3 pathway inhibits IL-1α induced interactions between human pancreatic stellate cells and pancreatic carcinoma cells and restricts cancer cell migration.Virus like particles as a platform for cancer vaccine development.Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells.Alterations in Pharmacokinetics of Gemcitabine and Erlotinib by Concurrent Administration of Hyangsayukgunja-Tang, a Gastroprotective Herbal Medicine.CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype.Investigation into metastatic processes and the therapeutic effects of gemcitabine on human pancreatic cancer using an orthotopic SUIT-2 pancreatic cancer mouse model.Targeting p21 activated kinase 1 (Pak1) to PAKup Pancreatic Cancer.
P2860
Q24627664-CA2B5E70-6FDF-468B-997B-15E1C9AD51B9Q26774636-8736D73D-B6FF-4A02-948D-1282C85B4E42Q26776524-4DBE648E-A5F3-4F52-A537-1E81C4927D3AQ27347648-602A1D6C-72EB-4556-9820-4C935B24B606Q28079456-7E37C9EB-5E7B-4E40-AB15-492642406A2FQ33645140-3D61922C-EDA5-4561-BEBB-B42A5EA957D6Q33801371-3C338831-2E76-4B0F-8C8E-6B3CB7F0E84AQ33821218-8124E2D1-FC74-4A12-88FF-47CD71DF5C69Q33827703-7F0F2B4E-E70C-441B-9518-1D09025CCF6AQ33886981-6AE14524-00BC-4B9C-A685-1B5989D5653CQ34405057-B73FF0A1-0BA3-49C8-8558-4B8D6F4B1DDEQ34513935-88922247-0A18-48BF-BE36-595E70EE4FDAQ34537580-A132925F-3438-4D0B-9DC3-D6AC4751FF4FQ34555337-958C1F52-A6C9-4C2B-9B0A-EE977DF23F21Q35720701-2DBD0CF0-C8E0-4C19-875E-A2677C0EC33EQ35741633-989F1BD2-3527-4D72-B207-F4A977B5DE8BQ35803650-311357BE-C2A8-42C7-B384-8B09D3FF307FQ35901707-846D6C8A-621B-42F2-AB86-F93FB407C551Q36267629-24D4B0E5-83EB-4E53-A463-E1BC9C33A2BCQ36290367-B11DA1FD-DA0F-4CCD-A39B-EDD16A93785DQ37327815-13E00BBA-385E-4694-B7EB-5642CD4D9F51Q37413497-663D7AF1-CD11-4F54-9C33-8786F80F5C8AQ37457758-65B1C330-641D-4363-85F6-466A6AF42A07Q37573308-8CE6BACA-7E66-4626-82D1-16E58F57F715Q37687464-743DAC3A-3C6F-4AC0-9221-5CF9EB5CA209Q38212152-78BB64BE-8480-4F58-9C58-B1D84424C7D2Q38372837-DA752D6E-7C15-44D4-82DA-A44784F40D96Q38743489-B3D1CB16-D025-4FF0-AB7F-D5048AAD5B1CQ38806041-0A599FE4-DBAD-415F-880A-D8D1B8704254Q38817911-A2CE1A35-B388-44DF-9B89-62A301D9B07DQ41815302-46A9D179-7074-4609-9EA7-EDC27BA7373AQ42339289-2B224C54-7BA4-4D22-822D-F78BB0A450D6Q42351657-11599257-B2E7-4B7A-BF3B-1A25552A7D34Q42393530-B9AB9667-15D8-491F-9E24-1074F852F117Q45324534-41915D5F-1DD7-4E16-9C91-FAEB11C612EAQ46560491-5D696A42-FBE7-42B5-A439-99697C26C7DDQ48004181-207E0170-C90F-48B0-9DF5-ED7A97757490Q48820342-BFE84CBA-900E-47DC-9143-B8BD482775DCQ50053288-DF7EAAFF-2346-49D2-B471-3E16177084CDQ53768938-1984AB2C-BA73-4587-86C8-1753D2A7EDF3
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pancreatic cancer: why is it so hard to treat?
@en
type
label
Pancreatic cancer: why is it so hard to treat?
@en
prefLabel
Pancreatic cancer: why is it so hard to treat?
@en
P2860
P356
P1476
Pancreatic cancer: why is it so hard to treat?
@en
P2093
Kenneth P Olive
Paul E Oberstein
P2860
P304
P356
10.1177/1756283X13478680
P577
2013-07-01T00:00:00Z